If you’re looking for a likely reason why Trump blocked Dr. Fauci from giving his medical opinion on hydroxychloroquine, see this @jonathanvswan scoop about the big fight between Fauci and Trump acolyte Peter Navarro at yesterday’s task force meeting—> https://t.co/hlHFiqlp5g— Philip Rucker (@PhilipRucker) April 6, 2020
According to Axios:
Then Navarro got up. He brought over a stack of folders and dropped them on the table. People started passing them around.
"And the first words out of his mouth are that the studies that he's seen, I believe they're mostly overseas, show 'clear therapeutic efficacy,'" said a source familiar with the conversation. "Those are the exact words out of his mouth."
Navarro's comments set off a heated exchange about how the Trump administration and the president ought to talk about the malaria drug, which Fauci and other public health officials stress is unproven to combat COVID-19.
Fauci pushed back against Navarro, saying that there was only anecdotal evidence that hydroxychloroquine works against the coronavirus.
Most members of the task force support a cautious approach to discussing the drug until it's proven.
Navarro, on the other hand, is convinced based on his reading that the drug works against the coronavirus and speaks about it enthusiastically.
In a fight over medical research, my money is on Dr. Fauci, not layman Navarro:
Dr. Schaffner cautioned that the results applied only to patients with relatively mild illness, like the ones in the study, and could not be generalized to advanced cases.So, a very strong "Yeah, maybe, who knows?" which Peter Navarro, non-scientist, wants to turn into "MIRACLE CURE!" Apparently Navarro thinks he's working for Jim Bakker.
“If you want to treat people who are already seriously ill, we don’t know how well this will work,” he said.
If the drug is helping, it is not clear how. There are two possible ways. In laboratory studies, it can stop the virus from invading cells. But hydroxychloroquine can also dial back an overactive immune system, which is why it can treat autoimmune diseases. And a powerful immune reaction to the coronavirus is suspected of playing a role in some of the severest cases of the disease.
“We don’t know which of the pharmacologic aspects of hydroxychloroquine are most active, the antiviral part, or the immunomodulatory part,” Dr. Schaffner said. “We don’t know, but it does reinforce the notion, as the authors say briefly, it reinforces the thinking about the nature of many of these pneumonias we are seeing, which seem to have an immune basis, as opposed to being secondary bacterial pneumonia, which we see so often in influenza.”
Then again, he might as well be.